+

CN110721333A - Antiallergic dressing used after anesthesia and preparation method thereof - Google Patents

Antiallergic dressing used after anesthesia and preparation method thereof Download PDF

Info

Publication number
CN110721333A
CN110721333A CN201911033815.9A CN201911033815A CN110721333A CN 110721333 A CN110721333 A CN 110721333A CN 201911033815 A CN201911033815 A CN 201911033815A CN 110721333 A CN110721333 A CN 110721333A
Authority
CN
China
Prior art keywords
extract
antiallergic
allergic
anesthesia
dressing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201911033815.9A
Other languages
Chinese (zh)
Inventor
吕治全
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Medical University
Original Assignee
Chongqing Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Medical University filed Critical Chongqing Medical University
Priority to CN201911033815.9A priority Critical patent/CN110721333A/en
Publication of CN110721333A publication Critical patent/CN110721333A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28Polysaccharides or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/618Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/238Saposhnikovia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/35Caprifoliaceae (Honeysuckle family)
    • A61K36/355Lonicera (honeysuckle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/538Schizonepeta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402Anaestetics, analgesics, e.g. lidocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/426Immunomodulating agents, i.e. cytokines, interleukins, interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明公开了一种用于麻醉后的抗过敏敷料及其制备方法,属于麻醉科医用敷料技术领域,所述抗过敏敷料包括无纺布和粘接在无纺布上的载药层,所述载药层为负载有抗过敏凝胶颗粒的海藻酸钙复合纤维制备而成的,所述抗过敏凝胶颗粒包括海藻酸钙壳层和装填在海藻酸钙壳层内的抗过敏药液。本发明的敷料具有抗过敏的作用,还可以减缓患者已出现的过敏症状,同时还具有止痛杀菌的功效。The invention discloses an anti-allergic dressing used after anesthesia and a preparation method thereof, belonging to the technical field of medical dressings in anesthesia. The drug-loading layer is prepared from calcium alginate composite fibers loaded with anti-allergic gel particles, and the anti-allergic gel particles include a calcium alginate shell layer and an anti-allergic liquid filled in the calcium alginate shell layer. . The dressing of the invention has an anti-allergic effect, can also alleviate the allergic symptoms that have occurred in a patient, and also has the effect of relieving pain and sterilizing.

Description

一种用于麻醉后的抗过敏敷料及其制备方法A kind of anti-allergic dressing for post-anesthesia and preparation method thereof

技术领域technical field

本发明涉及麻醉科医用敷料技术领域,尤其涉及一种用于麻醉后的抗过敏敷料及其制备方法。The invention relates to the technical field of anesthesia medical dressings, in particular to an anti-allergic dressing used after anesthesia and a preparation method thereof.

背景技术Background technique

有关麻醉技术,世界上最早的文字记载是出现在我国的汉朝,由中国古代著名外科专家、中医药学家华佗发明的麻沸汤。麻沸汤为中药汤剂相当于现在的口服全麻剂,口服后患者皮肤感觉丧失而便于实施手术。后来西医发明了各种麻醉剂,如现在盛行的利多卡因、布比卡因、普鲁卡因等等。麻醉是由药物或其他方法产生的一种中枢神经和周围神经系统的可逆性功能抑制,这种抑制的特点主要是感觉特别是痛觉的丧失。Regarding anesthesia technology, the earliest written record in the world is the Mafei Decoction invented by Hua Tuo, a famous ancient Chinese surgical expert and Chinese medicine scientist, which appeared in the Han Dynasty in my country. Ma Fei Tang is a traditional Chinese medicine decoction equivalent to the current oral general anesthesia. After oral administration, the patient loses skin sensation and facilitates the operation. Later, Western medicine invented various anesthetics, such as lidocaine, bupivacaine, procaine and so on. Anesthesia is a reversible functional inhibition of the central and peripheral nervous systems produced by drugs or other methods, which is mainly characterized by loss of sensation, especially pain.

现在麻醉不仅是应用于大型手术的感觉屏蔽,还应用于创伤口的止痛,便于创伤口的清理、缝合,麻醉过程中往往需要使用敷料,例如阻滞麻醉,是将局部麻醉药物注射于神经干或主要分支周围,以阻断神经末梢的传入刺激,使该神经分布区域产生麻醉效果,退针后用敷料将穿刺点覆盖。目前常用的敷料材料有纱布、油纱、藻酸钙敷料、水胶体敷料等,其中纱布、油纱等敷料覆盖处的皮肤由于反复接触消毒液及粘性敷料覆盖,加之气温升高的季节皮肤的汗液刺激,部分病人会出现穿刺点周边皮肤因出汗等情况而影响了透明敷料的粘性屏障作用。有些病人特别是老年人,长期使用会出现敷料边缘切迹对皮肤刺激而发生的刺激性皮炎。病人表现为敷料边缘的皮肤发红、痒、痛感、水泡等症状。其中,因藻酸钙敷料具有无毒性、无免疫原性、可生物降解性等优良性能被越来越广泛的使用,但是海藻酸钙敷料因其海藻酸钙纤维自身的力学性能差、强力不匀率高的特点,可纺性差,通常采用非织造形式制成,容易造成直角方向开裂,造成敷料强度低和耐久度差,敷料会发生翘起、脱落等情况。所以,目前急需一种强度高、不易撕裂的抗过敏海藻酸钙纤维敷料。Now anesthesia is not only used for sensory shielding in major surgery, but also for pain relief of wounds, which is convenient for wound cleaning and suturing. Dressings are often used during anesthesia, such as block anesthesia, which is to inject local anesthetics into the nerve trunk. Or around the main branch to block the afferent stimulation of nerve endings, so that the nerve distribution area has an anesthetic effect, and the puncture point is covered with a dressing after the needle is withdrawn. At present, the commonly used dressing materials include gauze, oil gauze, calcium alginate dressing, hydrocolloid dressing, etc. Among them, the skin covered by gauze, oil gauze and other dressings is covered by repeated contact with disinfectant and viscous dressings, and the skin in the season when the temperature rises. Sweat is irritated, and some patients may experience sweating of the skin around the puncture point, which affects the adhesive barrier function of the transparent dressing. Some patients, especially the elderly, may experience irritant dermatitis caused by skin irritation from the edge of the dressing after long-term use. The patient presented with redness, itching, pain, blisters and other symptoms of the skin at the edge of the dressing. Among them, calcium alginate dressings are more and more widely used because of their excellent properties such as non-toxicity, non-immunogenicity, and biodegradability. It has the characteristics of high uniformity and poor spinnability. It is usually made in non-woven form, which is easy to cause cracks in the right-angle direction, resulting in low strength and poor durability of the dressing, and the dressing will warp and fall off. Therefore, there is an urgent need for an anti-allergic calcium alginate fiber dressing with high strength and not easy to tear.

发明内容SUMMARY OF THE INVENTION

有鉴于此,本发明的目的是提供一种用于麻醉后的抗过敏敷料及其制备方法,该抗过敏敷料用于麻醉后对穿刺点的覆盖,制备的敷料具有抗过敏的作用,能够减缓患者已经出现的过敏症状,同时还具有止痛杀菌的功效。In view of this, the purpose of the present invention is to provide an anti-allergic dressing after anesthesia and a preparation method thereof, the anti-allergic dressing is used to cover the puncture point after anesthesia, and the prepared dressing has anti-allergic effect and can slow down Allergic symptoms that the patient has already appeared, but also has the effect of pain relief and bactericidal.

本发明通过以下技术手段解决上述技术问题:The present invention solves the above-mentioned technical problems through the following technical means:

一种用于麻醉后的抗过敏敷料,所述抗过敏敷料包括无纺布和粘接在无纺布上的载药层,所述载药层为负载有抗过敏凝胶颗粒的海藻酸钙复合纤维制备而成的,所述抗过敏凝胶颗粒包括海藻酸钙壳层和装填在海藻酸钙壳层内的抗过敏药液。An anti-allergic dressing used after anesthesia, the anti-allergic dressing comprises a non-woven fabric and a drug-loading layer bonded on the non-woven fabric, and the drug-loading layer is calcium alginate loaded with anti-allergic gel particles The anti-allergic gel particles are prepared from composite fibers, and the anti-allergic gel particles include a calcium alginate shell layer and an anti-allergic medicinal liquid filled in the calcium alginate shell layer.

进一步,所述海藻酸钙复合纤维主要由海藻酸钠和短棉纤维按照质量比(20-25):(4-8)复合制备而成。Further, the calcium alginate composite fiber is mainly prepared by compounding sodium alginate and short cotton fiber according to the mass ratio of (20-25):(4-8).

进一步,所述海藻酸钙复合纤维和抗过敏凝胶颗粒的质量比为(24-33):(3-8),所述抗过敏凝胶颗粒的粒径为0.2-0.5mm。Further, the mass ratio of the calcium alginate composite fiber and the anti-allergic gel particles is (24-33):(3-8), and the particle size of the anti-allergic gel particles is 0.2-0.5 mm.

进一步,所述抗过敏药液包括以下成分:尼泊金乙酯、薄荷脑提取物、地肤子提取物、珍珠粉、荆芥提取物、防风提取物、金银花提取物、一枝黄花提取物、半边莲提取物。Further, the anti-allergic liquid includes the following components: ethyl paraben, menthol extract, Kochia extract, pearl powder, Nepeta extract, parsnip extract, honeysuckle extract, goldenrod flower extract, Lobelia Extract.

进一步,所述抗过敏凝胶颗粒的包括以下重量份原料:40-56份羧甲基纤维素、35-45份海藻酸钠、10份甘油、0.1份尼泊金乙酯、1-2份薄荷脑提取物、1-3份地肤子提取物、2-3份珍珠粉、5-6份荆芥提取物、3-5份防风提取物、0.5-1份金银花提取物、0.05-0.1份一枝黄花提取物、0.05-0.2份半边莲提取物。Further, the anti-allergic gel particles include the following raw materials in parts by weight: 40-56 parts of carboxymethyl cellulose, 35-45 parts of sodium alginate, 10 parts of glycerin, 0.1 part of ethylparaben, 1-2 parts of Menthol Extract, 1-3 Parts Kochia Extract, 2-3 Parts Pearl Powder, 5-6 Parts Nepeta Extract, 3-5 Parts Parsnip Extract, 0.5-1 Parts Honeysuckle Extract, 0.05-0.1 Parts Parts Solidago Extract, 0.05-0.2 Parts Lobelia Extract.

进一步,所述无纺布与载药层的面积比为1:(0.8-0.9)。Further, the area ratio of the non-woven fabric to the drug-loading layer is 1:(0.8-0.9).

进一步,本发明还公开了所述抗过敏敷料的制备方法,将短棉纤维和抗过敏凝胶颗粒加入饱和的海藻酸钠溶液中,得到的混合纺丝液经湿法纺丝机的喷丝孔中喷出至45℃的凝固浴中,析出,得到的纤维经拉伸辊牵引拉伸,得到负载有抗过敏凝胶颗粒的海藻酸钙复合纤维,将干燥后的海藻酸钙复合纤维形成载药层;将无纺布于水蒸汽下蒸制20-30min,然后干燥至含水量为30-40%,将载药层加热至80-85℃,趁热将载药层粘粘于无纺布上,得到抗过敏敷料,于常温下自然风干,密封无菌保存。Further, the present invention also discloses the preparation method of the anti-allergic dressing. The short cotton fibers and the anti-allergic gel particles are added to the saturated sodium alginate solution, and the obtained mixed spinning solution is subjected to spinning by a wet spinning machine. It is sprayed out of the hole to a coagulation bath at 45°C, and precipitated. The obtained fiber is drawn and stretched by a drawing roller to obtain a calcium alginate composite fiber loaded with anti-allergic gel particles, and the dried calcium alginate composite fiber is formed. Drug-loading layer; steam the non-woven fabric under water vapor for 20-30min, then dry to a water content of 30-40%, heat the drug-loading layer to 80-85°C, and stick the drug-loading layer to the The anti-allergic dressing is obtained on the spinning cloth, which is naturally air-dried at room temperature, and sealed and stored aseptically.

进一步,所述载药层的制备包括以下步骤:Further, the preparation of the drug-loading layer includes the following steps:

混合纺丝液制备:将海藻酸钠缓慢溶解于去离子水中,以400-600rpm的速率搅拌1-2h,得到海藻酸钠溶液,将短棉纤维、消泡剂加入海藻酸钠溶液中,以1000-1500rpm搅拌1-2h后,再加入抗过敏凝胶颗粒,以300-500rpm的速率搅拌分散20-30min后,得到混合纺丝液;Preparation of mixed spinning solution: slowly dissolve sodium alginate in deionized water, stir at a speed of 400-600rpm for 1-2h to obtain sodium alginate solution, add short cotton fiber and defoamer to the sodium alginate solution, After stirring at 1000-1500rpm for 1-2h, add anti-allergic gel particles, and stir and disperse at a speed of 300-500rpm for 20-30min to obtain a mixed spinning solution;

凝固浴制备:配制乙醇-氯化钙混合溶液,并调节混合溶液pH=6.5-7,得到凝固浴;Preparation of coagulation bath: prepare a mixed solution of ethanol-calcium chloride, and adjust the pH of the mixed solution=6.5-7 to obtain a coagulation bath;

海藻酸钙复合纤维制备:在环境温度为30℃、相对湿度≤65%的条件下,湿法纺丝机的喷丝孔喷出混合纺丝液进入45℃的凝固浴中,单喷头纺丝速率为10ml/h,混合纺丝液于凝固浴中析出,得到纤维,经纤维拉伸辊牵引拉伸至1倍后用蒸馏水清洗,干燥后得到负载有抗过敏凝胶颗粒的海藻酸钙复合纤维,所述海藻酸钙复合纤维的直径为0.6-1mm;Preparation of calcium alginate composite fiber: Under the conditions of ambient temperature of 30 °C and relative humidity of ≤65%, the spinning hole of the wet spinning machine ejects the mixed spinning solution into a coagulation bath at 45 °C, and spins with a single nozzle. The rate is 10ml/h, and the mixed spinning solution is precipitated in the coagulation bath to obtain fibers, which are stretched to 1 times by the fiber drawing roller, washed with distilled water, and dried to obtain a calcium alginate composite loaded with anti-allergic gel particles. Fiber, the diameter of the calcium alginate composite fiber is 0.6-1mm;

载药层制备:将干燥后的海藻酸钙复合纤维采用经纬编织方法编织成厚度为0.5-0.8cm的载药层。Preparation of drug-loaded layer: the dried calcium alginate composite fiber is woven into a drug-loaded layer with a thickness of 0.5-0.8 cm by warp and weft weaving.

进一步,所述凝固浴与混合纺丝液的体积比为3:1。Further, the volume ratio of the coagulation bath to the mixed spinning solution is 3:1.

进一步,乙醇-氯化钙混合溶液中乙醇浓度为45-55wt%,所述氯化钙浓度为4-5wt%。Further, the ethanol concentration in the ethanol-calcium chloride mixed solution is 45-55 wt %, and the calcium chloride concentration is 4-5 wt %.

进一步,所述抗过敏凝胶颗粒的制备步骤如下:Further, the preparation steps of the anti-allergic gel particles are as follows:

将羧甲基纤维素钠加入去离子水中,待完全溶解后加入甘油、尼泊金乙酯搅拌均匀,再加入薄荷脑提取物、地肤子提取物、珍珠粉、荆芥提取物、防风提取物、金银花提取物、一枝黄花提取物、半边莲提取物混合成糊状物,将糊状物加入3-5wt%的海藻酸钠溶液中,采用25kHz的超声波分散成悬浮液,将悬浮液滴入饱和的乳酸钙溶液中,捞出,得到抗过敏凝胶颗粒。Add sodium carboxymethyl cellulose into deionized water, after it is completely dissolved, add glycerin and ethyl paraben and stir well, then add menthol extract, Kochia extract, pearl powder, Nepeta extract, and wind extract extract, honeysuckle extract, goldenrod extract, lobelia extract are mixed into a paste, the paste is added to 3-5wt% sodium alginate solution, dispersed into a suspension by 25kHz ultrasonic wave, the suspension droplets Put it into saturated calcium lactate solution, and remove it to obtain anti-allergic gel particles.

本发明提供的一种用于麻醉后的抗过敏敷料及其制备方法,有益效果如下:An anti-allergic dressing for anesthesia and a preparation method thereof provided by the present invention have the following beneficial effects:

一、本发明的抗过敏敷料用于固定静脉导管,敷料的双层结构中的表层为载药层,载药层直接接触皮肤,底层为医用无纺布;医用无纺布的阻菌效果和透气效果良好,并且防水性和伸缩性都较好,且面积大于载药层,所以底层将表层完全覆盖住,可以减少细菌、液体的侵入,而表层的载药层负载有抗过敏药液,可以避免患者对底层于载药层外侧的粘胶过敏,若已经发生过敏症状,可以缓解过敏的不良反应。1. The anti-allergic dressing of the present invention is used for fixing intravenous catheters. The surface layer in the double-layer structure of the dressing is a drug-carrying layer, the drug-carrying layer directly contacts the skin, and the bottom layer is a medical non-woven fabric; the antibacterial effect of the medical non-woven fabric and the The ventilation effect is good, and the waterproof and stretchability are good, and the area is larger than the drug-loading layer, so the bottom layer completely covers the surface layer, which can reduce the invasion of bacteria and liquid, and the drug-loading layer of the surface layer is loaded with anti-allergic liquid. It can prevent the patient from being allergic to the adhesive on the outer side of the drug-loading layer. If allergic symptoms have already occurred, the allergic adverse reactions can be alleviated.

二、海藻酸钙复合纤维无毒无害,是一种纯天然的绿色材料,可以将放置有静脉导管伤口处的渗出液吸收,去除细菌的滋生场所,还可以吸附细菌达到抗菌的目的。海藻酸钙复合纤维制备的时候将海藻酸钠和短棉纤维制备的混合纺丝液与抗过敏凝胶颗粒混合制备出来的海藻酸钙复合纤维上负载或者内部包裹有粒径为0.2-0.5mm的抗过敏凝胶颗粒,海藻酸钙复合纤维不仅具有抗菌的效果还具有抗过敏的的优点,而短棉纤维增加了海藻酸钙复合纤维的韧性。2. Calcium alginate composite fiber is non-toxic and harmless. It is a pure natural green material. It can absorb the exudate from the wound where the venous catheter is placed, remove the breeding place of bacteria, and can also absorb bacteria to achieve the purpose of antibacterial. When the calcium alginate composite fiber is prepared, the mixed spinning solution prepared by sodium alginate and short cotton fiber is mixed with anti-allergic gel particles. The anti-allergic gel particles, calcium alginate composite fiber not only has antibacterial effect but also has the advantages of anti-allergic, and short cotton fiber increases the toughness of calcium alginate composite fiber.

三、抗过敏凝胶颗粒里面含有多种中药提取物,具有抗过敏、消炎、抗菌、止痛、止痒的功效,与海藻酸钠混合制备成为悬浮液后滴加进乳酸钙溶液中,形成外部为海藻酸钙凝胶,内部为抗过敏药液的抗过敏凝胶颗粒,海藻酸钙凝胶具有一定的缓释作用,可以延长抗过敏药液的药效,达到持续给药的目的。3. The anti-allergic gel particles contain a variety of traditional Chinese medicine extracts, which have anti-allergic, anti-inflammatory, antibacterial, analgesic, and antipruritic effects. They are mixed with sodium alginate to prepare a suspension and then added dropwise to the calcium lactate solution to form an external It is calcium alginate gel with anti-allergic gel particles inside of anti-allergic liquid. Calcium alginate gel has a certain slow-release effect, which can prolong the efficacy of anti-allergic liquid and achieve the purpose of continuous administration.

具体实施方式Detailed ways

以下将结合具体实施例本发明进行详细说明:The present invention will be described in detail below in conjunction with specific embodiments:

实施例1:抗过敏敷料制备一Example 1: Anti-allergic dressing preparation one

制备抗过敏敷料应制备抗过敏凝胶颗粒,其制备方法如下:The preparation of anti-allergic dressing should prepare anti-allergic gel particles, and its preparation method is as follows:

将40g羧甲基纤维素钠加入500ml去离子水搅拌,待完全溶解后加入10g甘油、0.1g尼泊金乙酯搅拌均匀,再加入1g薄荷脑提取物、2g地肤子提取物、3g珍珠粉、5g荆芥提取物、3g防风提取物、0.5g金银花提取物、0.1g一枝黄花提取物、0.2g半边莲提取物混合成糊状物,将糊状物加入35g海藻酸钠制备的浓度为4wt%的海藻酸钠溶液中,采用25kHz的超声波分散成悬浮液,将悬浮液滴入饱和的乳酸钙溶液中,过滤得到抗过敏凝胶颗粒。经检测,制备得到的抗过敏凝胶颗粒的粒径为0.2-0.5mm。Add 40g of sodium carboxymethyl cellulose to 500ml of deionized water and stir. After it is completely dissolved, add 10g of glycerin and 0.1g of ethylparaben and stir evenly. Then add 1g of menthol extract, 2g of Kochia radix extract, and 3g of pearl. Powder, 5g Nepeta extract, 3g Parsnip extract, 0.5g Honeysuckle extract, 0.1g Solidago extract, 0.2g Lobelia extract were mixed into a paste, and the paste was added to 35g sodium alginate to prepare the concentration In a 4wt% sodium alginate solution, 25kHz ultrasonic wave is used to disperse into a suspension, drop the suspension into a saturated calcium lactate solution, and filter to obtain anti-allergic gel particles. After testing, the particle size of the prepared antiallergic gel particles is 0.2-0.5 mm.

制备完成抗过敏凝胶颗粒后制备载药层,其制备方法如下:After the antiallergic gel particles are prepared, the drug-loading layer is prepared, and the preparation method is as follows:

混合纺丝液制备:将200g海藻酸钠缓慢溶解于2000ml去离子水中,以400rpm的速率搅拌2h,得到饱和的海藻酸钠溶液,将40g 0.5-1mm长度的短棉纤维、2g DSA-5消泡剂加入饱和的海藻酸钠溶液中,以1000rpm搅拌2h后,再加入制备的30g抗过敏凝胶颗粒,以300rpm的速率搅拌20min后,得到混合纺丝液;Preparation of mixed spinning solution: 200g of sodium alginate was slowly dissolved in 2000ml of deionized water, stirred at a speed of 400rpm for 2h to obtain a saturated sodium alginate solution, and 40g of 0.5-1mm long short cotton fibers and 2g of DSA-5 were eliminated. The foaming agent was added to the saturated sodium alginate solution, and after stirring at 1000 rpm for 2 hours, 30 g of the prepared anti-allergic gel particles were added, and after stirring at a speed of 300 rpm for 20 minutes, a mixed spinning solution was obtained;

凝固浴制备:配制乙醇-氯化钙混合溶液,其中乙醇浓度为45wt%,氯化钙浓度为5wt%,并调节混合溶液pH=6.5,得到凝固浴,凝固浴与混合纺丝液的体积比为3:1;Preparation of coagulation bath: prepare a mixed solution of ethanol-calcium chloride, wherein the concentration of ethanol is 45wt%, the concentration of calcium chloride is 5wt%, and the pH of the mixed solution is adjusted to 6.5 to obtain a coagulation bath, and the volume ratio of the coagulation bath to the mixed spinning solution is 3:1;

海藻酸钙复合纤维制备:在环境温度为30℃、相对湿度≤65%的条件下,湿法纺丝机的喷丝孔喷出混合纺丝液进入45℃的凝固浴中,单喷头的纺丝速率为10ml/h,纺丝电压控制为15kv,纺丝液于凝固浴中析出,得到纤维,并经过拉伸辊牵引拉伸至1倍后用蒸馏水清洗,于35℃干燥后得到负载有抗过敏凝胶颗粒的海藻酸钙复合纤维,经测量,海藻酸钙复合纤维的直径为1mm左右;Preparation of calcium alginate composite fiber: Under the conditions of ambient temperature of 30 °C and relative humidity of ≤65%, the spinning hole of the wet spinning machine ejects the mixed spinning solution into the coagulation bath at 45 °C, and the spinning of single nozzle The spinning rate is 10ml/h, the spinning voltage is controlled to 15kv, the spinning solution is precipitated in the coagulation bath, and the fiber is obtained, which is stretched to 1 times by the drawing roller, washed with distilled water, and dried at 35 °C to obtain a loaded fiber. The calcium alginate composite fiber of the anti-allergic gel particles is measured, and the diameter of the calcium alginate composite fiber is about 1mm;

载药层制备:将干燥后的海藻酸钙复合纤维采用经纬编织方法编织成宽度为5×5cm,厚度为0.8cm的矩形载药层。Preparation of drug-loading layer: The dried calcium alginate composite fiber is woven into a rectangular drug-loading layer with a width of 5×5cm and a thickness of 0.8cm by warp and weft knitting.

抗过敏敷料制备:Anti-allergic dressing preparation:

将6.2×6.2cm医用无纺布于水蒸汽下蒸制20min,然后取出,干燥至含水量为30%,将制备的将载药层水浴加热至80℃,趁热将载药层粘粘于无纺布上,压制30s后于常温下自然风干,密封无菌保存。Steam the 6.2×6.2cm medical non-woven fabric under water vapor for 20min, then take it out, dry it to a water content of 30%, heat the prepared drug-loading layer in a water bath to 80°C, and stick the drug-loading layer on the On the non-woven fabric, after pressing for 30s, air-dry naturally at room temperature, and seal it for aseptic storage.

实施例2:抗过敏敷料制备二Example 2: Anti-allergic dressing preparation II

制备抗过敏敷料应制备抗过敏凝胶颗粒,其制备方法如下:The preparation of anti-allergic dressing should prepare anti-allergic gel particles, and its preparation method is as follows:

将50g羧甲基纤维素钠加入500ml去离子水搅拌,待完全溶解后加入10g甘油、0.1g尼泊金乙酯搅拌均匀,再加入2g薄荷脑提取物、3g地肤子提取物、2g珍珠粉、6g荆芥提取物、4g防风提取物、0.5g金银花提取物、0.05g一枝黄花提取物、0.05g半边莲提取物混合成糊状物,将糊状物加入40g海藻酸钠制备的浓度为3wt%的海藻酸钠溶液中,采用25kHz的超声波分散成悬浮液,将悬浮液滴入饱和的乳酸钙溶液中,过滤得到抗过敏凝胶颗粒。经检测,制备得到的抗过敏凝胶颗粒的粒径为0.2-0.5mm。Add 50g of sodium carboxymethyl cellulose to 500ml of deionized water and stir. After it is completely dissolved, add 10g of glycerin and 0.1g of ethylparaben and stir evenly. Then add 2g of menthol extract, 3g of Kochia radix extract, and 2g of pearl. Powder, 6g Nepeta extract, 4g Parsnip extract, 0.5g Honeysuckle extract, 0.05g Solidago extract, 0.05g Lobelia extract were mixed into a paste, and the paste was added to 40g sodium alginate to prepare the concentration In 3wt% sodium alginate solution, 25kHz ultrasonic wave is used to disperse into a suspension, drop the suspension into a saturated calcium lactate solution, and filter to obtain anti-allergic gel particles. After testing, the particle size of the prepared antiallergic gel particles is 0.2-0.5 mm.

制备完成抗过敏凝胶颗粒后制备载药层,其制备方法如下:After the antiallergic gel particles are prepared, the drug-loading layer is prepared, and the preparation method is as follows:

混合纺丝液制备:将250g海藻酸钠缓慢溶解于2500ml去离子水中,以500rpm的速率搅拌1.5h,得到饱和的海藻酸钠溶液,将80g0.5-1mm长度的短棉纤维、2g DSA-5消泡剂加入饱和的海藻酸钠溶液中,以1200rpm搅拌1h后,再加入制备的70g抗过敏凝胶颗粒,以300rpm的速率搅拌25min后得到混合纺丝液;Preparation of mixed spinning solution: Slowly dissolve 250g of sodium alginate in 2500ml of deionized water, stir at a rate of 500rpm for 1.5h to obtain a saturated sodium alginate solution, mix 80g of 0.5-1mm long short cotton fibers, 2g of DSA- 5. The defoamer is added to the saturated sodium alginate solution, and after stirring at 1200 rpm for 1 hour, 70 g of the prepared anti-allergic gel particles are added, and the mixed spinning solution is obtained after stirring at a speed of 300 rpm for 25 minutes;

凝固浴制备:配制乙醇-氯化钙混合溶液,其中乙醇浓度为50wt%,氯化钙浓度为4wt%50wt%乙醇-4wt%氯化钙混合溶液,并调节混合溶液pH=7,得到凝固浴,凝固浴与混合纺丝液的体积比为3:1;Preparation of coagulation bath: prepare a mixed solution of ethanol-calcium chloride, wherein the concentration of ethanol is 50wt%, the concentration of calcium chloride is 4wt%, the concentration of 50wt% ethanol-4wt% calcium chloride mixed solution, and the pH of the mixed solution is adjusted to 7 to obtain a coagulation bath , the volume ratio of coagulation bath and mixed spinning solution is 3:1;

海藻酸钙复合纤维制备:在环境温度为30℃、相对湿度≤65%的条件下,湿法纺丝机的喷丝孔喷出混合纺丝液进入45℃的凝固浴中,单喷头的纺丝速率为10ml/h,纺丝电压控制为15kv,纺丝液于凝固浴中析出,得到纤维,并经过拉伸辊牵引拉伸至1倍后用蒸馏水清洗,于30℃干燥后得到负载有抗过敏凝胶颗粒的海藻酸钙复合纤维,经测量,海藻酸钙复合纤维的直径0.9mm左右;Preparation of calcium alginate composite fiber: Under the conditions of ambient temperature of 30 °C and relative humidity of ≤65%, the spinning hole of the wet spinning machine ejects the mixed spinning solution into the coagulation bath at 45 °C, and the spinning of single nozzle The spinning rate was 10ml/h, the spinning voltage was controlled to 15kv, the spinning solution was precipitated in the coagulation bath, and the fiber was obtained, which was stretched to 1 times by the drawing roller, washed with distilled water, and dried at 30 °C to obtain a loaded fiber. The calcium alginate composite fiber of the anti-allergic gel particles is measured, and the diameter of the calcium alginate composite fiber is about 0.9mm;

载药层制备:将干燥后的海藻酸钙复合纤维采用经纬编织方法编织成宽度为5×5cm,厚度为0.5cm的矩形载药层。Preparation of drug-loaded layer: The dried calcium alginate composite fiber is woven into a rectangular drug-loaded layer with a width of 5×5cm and a thickness of 0.5cm by warp and weft weaving.

抗过敏敷料制备:Anti-allergic dressing preparation:

将5.6×5.6cm医用无纺布于水蒸汽下蒸制30min,然后取出,干燥至含水量为35%,将制备的将载药层水浴加热至82℃,趁热将载药层粘粘于无纺布上,压制30s后于常温下自然风干,密封无菌保存。The 5.6×5.6cm medical non-woven fabric was steamed under water vapor for 30min, then taken out, dried to a water content of 35%, heated to 82°C in a water bath of the prepared drug-loaded layer, and then adhered to the drug-loaded layer while it was still hot. On the non-woven fabric, after pressing for 30s, air-dry naturally at room temperature, and seal it for aseptic storage.

实施例3:抗过敏敷料制备三Example 3: Anti-allergic dressing preparation three

制备抗过敏敷料应制备抗过敏凝胶颗粒,其制备方法如下:The preparation of anti-allergic dressing should prepare anti-allergic gel particles, and its preparation method is as follows:

将60g羧甲基纤维素钠加入500ml去离子水搅拌,待完全溶解后加入10g甘油、0.1g尼泊金乙酯搅拌均匀,再加入2g薄荷脑提取物、1g地肤子提取物、2g珍珠粉、6g荆芥提取物、5g防风提取物、1g金银花提取物、0.1g一枝黄花提取物、0.1g半边莲提取物混合成糊状物,将糊状物加入45g海藻酸钠制备的浓度为3wtwt%的海藻酸钠溶液中,采用25kHz的超声波分散成悬浮液,将悬浮液滴入饱和的乳酸钙溶液中,过滤得到抗过敏凝胶颗粒。经检测,制备得到的抗过敏凝胶颗粒的粒径为0.2-0.5mm。Add 60g of sodium carboxymethyl cellulose to 500ml of deionized water and stir. After it is completely dissolved, add 10g of glycerin and 0.1g of ethyl paraben and stir evenly. Then add 2g of menthol extract, 1g of Kochia seed extract and 2g of pearl. Powder, 6g Nepeta extract, 5g Parsnip extract, 1g honeysuckle extract, 0.1g Solidago extract, 0.1g Lobelia extract were mixed into a paste, and the paste was added to 45g sodium alginate to prepare a concentration of In 3wtwt% sodium alginate solution, 25kHz ultrasonic wave is used to disperse into a suspension, drop the suspension into a saturated calcium lactate solution, and filter to obtain anti-allergic gel particles. After testing, the particle size of the prepared antiallergic gel particles is 0.2-0.5 mm.

制备完成抗过敏凝胶颗粒后制备载药层,其制备方法如下:After the antiallergic gel particles are prepared, the drug-loading layer is prepared, and the preparation method is as follows:

混合纺丝液制备:将200g海藻酸钠缓慢溶解于2000ml去离子水中,以600rpm的速率搅拌2h,得到饱和的海藻酸钠溶液,将60g 0.5-1mm长度的短棉纤维、2g DSA-5消泡剂加入饱和的海藻酸钠溶液中,以1500rpm搅拌1h后,再加入制备的80g抗过敏凝胶颗粒,以300rpm的速率搅拌30min后得到混合纺丝液;Preparation of mixed spinning solution: slowly dissolve 200g of sodium alginate in 2000ml of deionized water, stir at a rate of 600rpm for 2h to obtain a saturated sodium alginate solution, dissolve 60g of 0.5-1mm long short cotton fibers and 2g of DSA-5. The foaming agent was added to the saturated sodium alginate solution, and after stirring at 1500 rpm for 1 hour, 80 g of the prepared anti-allergic gel particles were added, and the mixed spinning solution was obtained after stirring at a speed of 300 rpm for 30 minutes;

凝固浴制备:配制乙醇-氯化钙混合溶液,其中乙醇浓度为55wt%,氯化钙浓度为4wt%,并调节混合溶液pH=7,得到凝固浴,凝固浴与混合纺丝液的体积比为3:1;Preparation of coagulation bath: prepare a mixed solution of ethanol-calcium chloride, wherein the concentration of ethanol is 55wt%, the concentration of calcium chloride is 4wt%, and the pH of the mixed solution is adjusted to 7 to obtain a coagulation bath, the volume ratio of the coagulation bath to the mixed spinning solution is 3:1;

海藻酸钙复合纤维制备:在环境温度为30℃、相对湿度≤65%的条件下,湿法纺丝机的喷丝孔喷出混合纺丝液进入45℃的凝固浴中,单喷头的纺丝速率为10ml/h,纺丝电压控制为15kv,纺丝液于凝固浴中析出,得到纤维,并经过拉伸辊牵引拉伸至1倍后用蒸馏水清洗,于30℃干燥后得到负载有抗过敏凝胶颗粒的海藻酸钙复合纤维,经测量,海藻酸钙复合纤维的直径0.7mm左右;Preparation of calcium alginate composite fiber: Under the conditions of ambient temperature of 30 °C and relative humidity of ≤65%, the spinning hole of the wet spinning machine ejects the mixed spinning solution into the coagulation bath at 45 °C, and the spinning of single nozzle The spinning rate was 10ml/h, the spinning voltage was controlled to 15kv, the spinning solution was precipitated in the coagulation bath, and the fiber was obtained, which was stretched to 1 times by the drawing roller, washed with distilled water, and dried at 30 °C to obtain a loaded fiber. The calcium alginate composite fiber of the anti-allergic gel particles is measured, and the diameter of the calcium alginate composite fiber is about 0.7mm;

载药层制备:将干燥后的海藻酸钙复合纤维采用经纬编织方法编织成宽度为5×5cm,厚度为0.7cm的矩形载药层。Preparation of drug-loading layer: The dried calcium alginate composite fiber is woven into a rectangular drug-loading layer with a width of 5×5cm and a thickness of 0.7cm by warp and weft weaving.

抗过敏敷料制备:Anti-allergic dressing preparation:

将6×6cm医用无纺布于水蒸汽下蒸制25min,然后取出,干燥至含水量为40%,将制备的将载药层水浴加热至85℃,趁热将载药层粘粘于无纺布上,压制30s后于常温下自然风干,密封无菌保存。Steam the 6×6cm medical non-woven fabric under water vapor for 25min, then take it out, dry it to a moisture content of 40%, heat the prepared drug-loading layer in a water bath to 85°C, and stick the drug-loading layer to the non-woven fabric while it is still hot. On the spinning cloth, after pressing for 30s, air-dry naturally at room temperature, and seal it for aseptic storage.

将实施例1-3制备的抗过敏敷料进行测量,干抗过敏敷料断裂强度3.0~3.5cN/dtex,湿抗过敏敷料断裂强度为2.0~2.9cN/dtex,说明制备的抗过敏敷料强度够高,持久耐用。The anti-allergic dressings prepared in Examples 1-3 were measured, and the breaking strength of the dry anti-allergic dressing was 3.0-3.5 cN/dtex, and the breaking strength of the wet anti-allergic dressing was 2.0-2.9 cN/dtex, indicating that the prepared anti-allergic dressing was strong enough ,Durable.

以上实施例仅用以说明本发明的技术方案而非限制,尽管参照较佳实施例对本发明进行了详细说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的宗旨和范围,其均应涵盖在本发明的权利要求范围当中。本发明未详细描述的技术、形状、构造部分均为公知技术。The above embodiments are only used to illustrate the technical solutions of the present invention and not to limit them. Although the present invention has been described in detail with reference to the preferred embodiments, those of ordinary skill in the art should understand that the technical solutions of the present invention can be modified or equivalently replaced. Without departing from the spirit and scope of the technical solutions of the present invention, all of them should be included in the scope of the claims of the present invention. The technology, shape, and structural part that are not described in detail in the present invention are all well-known technologies.

Claims (9)

1. The utility model provides an antiallergic dressing for after anesthesia, its characterized in that, antiallergic dressing includes the non-woven fabrics and bonds the medicine-carrying layer on the non-woven fabrics, the medicine-carrying layer is prepared for the calcium alginate composite fiber who loads the antiallergic gel granule, the antiallergic gel granule includes calcium alginate shell and fills the antiallergic liquid in calcium alginate shell.
2. The anti-allergic dressing used after anesthesia is characterized in that the calcium alginate composite fiber is mainly prepared from sodium alginate and short cotton fiber according to the mass ratio of (20-25): (4-8) compounding and preparing.
3. The anti-allergic dressing used after anesthesia is characterized in that the mass ratio of the calcium alginate composite fiber to the anti-allergic gel particles is (24-33) - (3-8), and the particle size of the anti-allergic gel particles is 0.2-0.5 mm.
4. The anti-allergic dressing used after anesthesia of claim 3, wherein the anti-allergic liquid comprises the following components: ethyl hydroxybenzoate, menthol extract, fructus Kochiae extract, pearl powder, herba Schizonepetae extract, radix Saposhnikoviae extract, flos Lonicerae extract, herba Solidaginis extract, and herba Lobeliae chinensis extract.
5. The antiallergic dressing used after anesthesia as claimed in claim 4, wherein the antiallergic gel particles comprise the following raw materials in parts by weight: 40-56 parts of carboxymethyl cellulose, 35-45 parts of sodium alginate, 10 parts of glycerol, 0.1 part of ethylparaben, 1-2 parts of menthol extract, 1-3 parts of fructus kochiae extract, 2-3 parts of pearl powder, 5-6 parts of herba schizonepetae extract, 3-5 parts of radix sileris extract, 0.5-1 part of honeysuckle extract, 0.05-0.1 part of goldenrod extract and 0.05-0.2 part of Chinese lobelia extract.
6. The method for preparing an antiallergic dressing used after anesthesia as set forth in claim 5, characterized in that the method comprises the following steps:
adding short cotton fibers and antiallergic gel particles into a saturated sodium alginate solution, spraying the obtained mixed spinning solution into a coagulating bath at 45 ℃ through a spinneret orifice of a wet spinning machine, separating out, drawing and stretching the obtained fibers through a drawing roller to obtain calcium alginate composite fibers loaded with the antiallergic gel particles, and forming a drug-loaded layer on the dried calcium alginate composite fibers; steaming nonwoven fabric in water vapor for 20-30min, drying to water content of 30-40%, heating the medicine-carrying layer to 80-85 deg.C, sticking the medicine-carrying layer on the nonwoven fabric while it is hot to obtain antiallergic dressing, naturally air drying at room temperature, sealing, and aseptically storing.
7. The preparation method of the antiallergic dressing used after anesthesia as claimed in claim 6, characterized in that the preparation method of the drug-loaded layer comprises the following steps:
preparing mixed spinning solution: slowly dissolving sodium alginate in deionized water, stirring at the speed of 400-;
preparing a coagulating bath: preparing an ethanol-calcium chloride mixed solution, and adjusting the pH value of the mixed solution to 6.5-7 to obtain a coagulating bath;
preparing calcium alginate composite fibers: under the conditions that the ambient temperature is 30 ℃ and the relative humidity is less than or equal to 65%, a spinneret orifice of a wet spinning machine sprays mixed spinning solution into a coagulation bath at the temperature of 45 ℃, the single-nozzle spinning speed is 10ml/h, the mixed spinning solution is separated out from the coagulation bath to obtain fibers, a fiber drawing roller is drawn and stretched to 1 time, then the fibers are cleaned by distilled water, and the calcium alginate composite fibers loaded with antiallergic gel particles are obtained after drying, wherein the diameter of the calcium alginate composite fibers is 0.6-1 mm;
preparing a drug-loaded layer: the dried calcium alginate composite fiber is woven into a drug-loaded layer with the thickness of 0.5-0.8cm by adopting a warp-weft weaving method.
8. The method for preparing an antiallergic dressing used after anesthesia as claimed in claim 7, wherein the ethanol concentration in the ethanol-calcium chloride mixed solution is 45-55 wt%, and the calcium chloride concentration is 4-5 wt%.
9. The method for preparing an antiallergic dressing used after anesthesia as claimed in claim 8, wherein the antiallergic gel particles are prepared by the following steps:
adding sodium carboxymethylcellulose into deionized water, dissolving completely, adding glycerol and ethylparaben, stirring, adding Mentholum extract, Kochiae fructus extract, Margarita powder, herba Schizonepetae extract, radix Saposhnikoviae extract, flos Lonicerae extract, herba Solidaginis extract, and herba Lobeliae chinensis extract, mixing to obtain paste, adding the paste into 3-5 wt% sodium alginate solution, dispersing with 25kHz ultrasonic wave to obtain suspension, dripping the suspension into saturated calcium lactate solution, and taking out to obtain antiallergic gel granule.
CN201911033815.9A 2019-10-25 2019-10-25 Antiallergic dressing used after anesthesia and preparation method thereof Pending CN110721333A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911033815.9A CN110721333A (en) 2019-10-25 2019-10-25 Antiallergic dressing used after anesthesia and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911033815.9A CN110721333A (en) 2019-10-25 2019-10-25 Antiallergic dressing used after anesthesia and preparation method thereof

Publications (1)

Publication Number Publication Date
CN110721333A true CN110721333A (en) 2020-01-24

Family

ID=69222235

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911033815.9A Pending CN110721333A (en) 2019-10-25 2019-10-25 Antiallergic dressing used after anesthesia and preparation method thereof

Country Status (1)

Country Link
CN (1) CN110721333A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060211972A1 (en) * 2003-03-28 2006-09-21 Brian Nielsen Wound dressing
WO2009141633A2 (en) * 2008-05-23 2009-11-26 Convatec Technologies Inc. Polysaccharide nanofibres having antimicrobial properties
CN103436992A (en) * 2013-08-29 2013-12-11 浙江理工大学 Method for preparing nano drug-carrying capsule-loaded alginate fibers
CN105169137A (en) * 2015-10-23 2015-12-23 东莞市达庆医疗器械有限公司 Antiallergic gel dressing and preparation method thereof
CN106975095A (en) * 2017-04-11 2017-07-25 南阳师范学院 A kind of antibacterial medical auxiliary material and preparation method thereof
CN107469131A (en) * 2017-08-29 2017-12-15 北京化工大学常州先进材料研究院 A kind of calcium alginate biology based composite dressing for medical use and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060211972A1 (en) * 2003-03-28 2006-09-21 Brian Nielsen Wound dressing
WO2009141633A2 (en) * 2008-05-23 2009-11-26 Convatec Technologies Inc. Polysaccharide nanofibres having antimicrobial properties
CN103436992A (en) * 2013-08-29 2013-12-11 浙江理工大学 Method for preparing nano drug-carrying capsule-loaded alginate fibers
CN105169137A (en) * 2015-10-23 2015-12-23 东莞市达庆医疗器械有限公司 Antiallergic gel dressing and preparation method thereof
CN106975095A (en) * 2017-04-11 2017-07-25 南阳师范学院 A kind of antibacterial medical auxiliary material and preparation method thereof
CN107469131A (en) * 2017-08-29 2017-12-15 北京化工大学常州先进材料研究院 A kind of calcium alginate biology based composite dressing for medical use and preparation method thereof

Similar Documents

Publication Publication Date Title
CN104758977B (en) A kind of alginate dressing for treating bedsore and preparation method thereof
CN107898716B (en) A kind of preparation method of nanofiber dry mask
CN103893815B (en) A kind of scalds and burns dressing utilizing coaxial electrostatic spinning legal system standby and preparation method thereof
CN103394114B (en) A kind of preparation method of medical dressing chitosan-based superfine fiber carrier material
CN108187120B (en) A kind of anesthesiology medical analgesic and hemostatic dressing and preparation method thereof
CN103055344B (en) Bacterial cellulose/chitosan composite medical dressing and preparation method thereof
CN103550817B (en) A kind of Bacterial cellulose/shitosan composite sponge dressing and preparation method thereof
CN105970327B (en) A kind of health care regenerated celulose fibre containing stone needle and preparation method thereof
CN107237005B (en) A kind of alginic acid and chitosan bicomponent fiber and preparation method thereof
CN110787317A (en) Department of anesthesia uses hemostatic sponge
CN104383585B (en) A kind of three-dimensional manometer composite adhesive bandage and preparation and application thereof
CN105031714A (en) Adhesive bandage and method for manufacturing same
CN107130333A (en) A kind of alginic acid and chitosan shuffling fiber and preparation method thereof
CN105251042A (en) Medical absorbable polyglycolic acid (PGA) operation suture line and preparing method
CN110433322A (en) A kind of the wet process spunlace non-woven spontaneous heating dressing and production technology of medicine film of generating heat
CN114259598B (en) Preparation method of antibacterial healing-promoting wound dressing
CN102995295B (en) Panax pseudo-ginseng non-woven fabrics and method for preparing same
CN105879106A (en) Graphene medical cotton and preparation method thereof
CN110721333A (en) Antiallergic dressing used after anesthesia and preparation method thereof
CN110917404B (en) Pain relieving type double-layer artificial skin, preparation device and preparation method
CN104324412A (en) Bamboo chitosan functional dressing
CN111249515A (en) Antibacterial, anti-inflammatory and biomedical dressing for promoting wound healing and preparation method thereof
CN107261189B (en) Preparation method of sisal fiber environment-friendly medical gauze
CN107412520A (en) A kind of antibacterial anti hemorrhagic ointment, medicine and preparation method thereof
CN110042494A (en) A kind of functional fibre combination process

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20200124

RJ01 Rejection of invention patent application after publication
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载